SCHEMBL5837580

SCHEMBL5837580

Cc1cn(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCCC3)c2)c(=O)n1CC(O)CN1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.37
RAD52 P43351 1/20 0.36
NLRP1 Q9C000 1/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ABCB1 P08183 1/20 0.34
GAA P10253 1/20 0.34
GLA P06280 1/20 0.34
HRH1 P35367 3/20 0.34
CCR3 P51677 3/20 0.34
MAPT P10636 2/20 0.34
KCNH2 Q12809 2/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CNR2 P34972 3/20 0.33
CNR1 P21554 2/20 0.33
HTT P42858 1/20 0.33
CCR1 P32246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838211 0.92 P2RX7 (0.38) P2RX7ALDH1A1MAPTTP53POLB
SCHEMBL5838500 0.91 P2RX7 (0.39) P2RX7MAPTTP53POLBCNR2
SCHEMBL5838989 0.89 P2RX7 (0.47) P2RX7KDM4EALDH1A1GAAMAPT
SCHEMBL5838903 0.89 P2RX7 (0.37) P2RX7HRH1CCR3MAPTKCNH2
SCHEMBL5838488 0.86 P2RX7 (0.39) P2RX7ALDH1A1MAPTTP53POLB
SCHEMBL6260746 0.86 P2RX7 (0.34) P2RX7MAPTTP53POLBCNR2
SCHEMBL5843079 0.85 P2RX7 (0.39) P2RX7MAPTTP53POLBCNR2
SCHEMBL5837096 0.85 P2RX7 (0.39) P2RX7MAPTTP53POLBCNR2
SCHEMBL5838943 0.85 P2RX7 (0.39) P2RX7KDM4EALDH1A1MAPTCNR2
SCHEMBL5957165 0.85 P2RX7 (0.39) P2RX7ALDH1A1HRH1CCR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor DOMBROSKI MARK A 2006-09-28 US disclosed
US-7071223-B1 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2006-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885RAD52 4117/4885NLRP1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.